Regulation of TGF-β Family Signaling by Inhibitory Smads
Open accessThe DOI matches its Crossref record; 210 of the 211 references it cites were found in a registry or an index.
Abstract
Inhibitory Smads (I-Smads) have conserved carboxy-terminal MH2 domains but highly divergent amino-terminal regions when compared with receptor-regulated Smads (R-Smads) and common-partner Smads (co-Smads). Smad6 preferentially inhibits Smad signaling initiated by the bone morphogenetic protein (BMP) type I receptors ALK-3 and ALK-6, whereas Smad7 inhibits both transforming growth factor β (TGF-β)- and BMP-induced Smad signaling. I-Smads also regulate some non-Smad signaling pathways. Here, we discuss the vertebrate I-Smads, their roles as inhibitors of Smad activation and regulators of receptor stability, as scaffolds for non-Smad signaling, and their possible roles in the nucleus. We also discuss the posttranslational modification of I-Smads, including phosphorylation, ubiquitylation, acetylation, and methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RAB11 285, which is responsible for endosomal recycling of TGFβ receptors 286, is recruited to the cilium in a process that is mediated by the subdistal appendage protein, CEP128 287. Consequently, loss of CEP128 leads to impaired phosphorylation of R-SMADs, which in zebrafish is associated with defective organ development 287.”
From Cellular signalling by primary cilia in development, organ function and disease (2019) · cites this paper as [287]
In the citing paper
“Also, non-mutational mechanisms impair the growth inhibitory response to TGF-β. In advanced tumors, TGFBR2 or SMAD2 genes are frequently silenced by histone and DNA methylation122,123. Additionally, increased inhibitory Smad6 or Smad7 expression in various carcinomas, including PDAC, attenuates Smad signaling124,125, whereas increased expression of the Smad corepressors c-Ski or SnoN, observed in”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [124]
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857 · cited 1×
“TGF-b family ligands trigger signaling through hetero-oligomerization of two types of transmembrane receptors with intrinsic serine-threonine kinase activities: the type I and type II receptors (Shi and Massagué 2003).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundNon-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749 · cited 1×
“…# 2017 Cold Spring Harbor Laboratory Press; all rights reserved; doi: 10.1101/cshperspect.a022095 Cite this article as Cold Spring Harb Perspect Biol 2017;9:a022095 1 tivated receptors can transmit signals independent of Smad proteins (non-Smad signaling pathways) (Zhang 2009).”
BackgroundInfluentialIdentification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundHayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSMAD proteins control DROSHA-mediated microRNA maturation
Davis, B. N., Hilyard, A. C., Lagna, G., & Hata, A. (2008) · Nature · doi:10.1038/nature07086 · Cited by 1,244 · cited 1×
“Activated Smad proteins promote the maturation of miR-21 independent of Smad4 by associating with the stem region of pri-miR-21 (Davis et al. 2008).”
BackgroundSmad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205 · cited 1×
“2A) (Kavsak et al. 2000; Ebisawa et al. 2001; Murakami et al. 2003).”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundFantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135 · cited 1×
“3), leading to enhanced TGF-b signaling and acquisition of regulatory properties by these cells, including an antiproliferative effect on CD4þ T cells (Fantini et al. 2004).”
BackgroundSmad6 inhibits signalling by the TGF-β superfamily
Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J.-I., Kawabata, M., & Miyazono, K. (1997) · Nature · doi:10.1038/39355 · Cited by 1,029 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSelf-citation
Research works printed but not linked: 1
- 10.1172/jci200112367 · doi:10.1172/jci200112367 · Paper page
Cited by
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
Hao, Y., Baker, D., & ten Dijke, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112767 · Cited by 1,142
“SMAD7 can also attenuate signaling by recruiting 119 phosphatases to the activated TGF-β receptor, which mediate receptor inactivation by the 120 dephosphorylation of specific amino acid residues [20].”
BackgroundTGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
TGF-β signaling in health and disease
Massagué, J., & Sheppard, D. (2023) · Cell · doi:10.1016/j.cell.2023.07.036 · Cited by 890
Contextual determinants of TGFβ action in development, immunity and cancer
David, C. J., & Massagué, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0007-0 · Cited by 851
Cellular signalling by primary cilia in development, organ function and disease
Anvarian, Z., Mykytyn, K., Mukhopadhyay, S., Pedersen, L. B., & Christensen, S. T. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0116-9 · Cited by 845
Specificity, versatility, and control of TGF-β family signaling
Derynck, R., & Budi, E. H. (2019) · Science Signaling · doi:10.1126/scisignal.aav5183 · Cited by 785
Non-Smad Signaling Pathways of the TGF-β Family
Zhang, Y. E. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022129 · Cited by 697
Endothelial to Mesenchymal Transition: Role in Physiology and in the Pathogenesis of Human Diseases
Piera-Velazquez, S., & Jimenez, S. A. (2019) · Physiological Reviews · doi:10.1152/physrev.00021.2018 · Cited by 662
“Two inhibitory Smad proteins, Smad6 and Smad7, abrogate or modulate TGF- -induced signaling cascades and are potent negative regulators of TGF- -induced gene expression responses (139, 219, 232).”
BackgroundTGF-β Signaling in Lung Health and Disease
Saito, A., Horie, M., & Nagase, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082460 · Cited by 490
“Intracellular Smad7 is known to inhibit TGF-β signaling through various mechanisms, and is important as a negative feedback regulator [20,21].”
BackgroundTGF-β1 – A truly transforming growth factor in fibrosis and immunity
Lodyga, M., & Hinz, B. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.010 · Cited by 458
Zhang, T., Wang, X.-F., Wang, Z.-C., Lou, D., Fang, Q.-Q., Hu, Y.-Y., Zhao, W.-Y., Zhang, L.-Y., Wu, L.-H., & Tan, W.-Q. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110287 · Cited by 438
Wu, M., Wu, S., Chen, W., & Li, Y.-P. (2024) · Cell Research · doi:10.1038/s41422-023-00918-9 · Cited by 445
“277 Therefore, the inhibitory functions of I-SMADs largely depend on their direct interactions with the type I receptors or R-SMADs.”
BackgroundTGF-β Signaling in Control of Cardiovascular Function
Goumans, M.-J., & ten Dijke, P. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022210 · Cited by 360
Pakshir, P., Noskovicova, N., Lodyga, M., Son, D. O., Schuster, R., Goodwin, A., Karvonen, H., & Hinz, B. (2020) · Journal of Cell Science · doi:10.1242/jcs.227900 · Cited by 293
“Inhibitory Smad7 antagonizes TGF-β signaling by inhibiting Smad-binding sites on the receptor (Miyazawa and Miyazono, 2017).”
BackgroundTGF-β Family Signaling in Mesenchymal Differentiation
Grafe, I., Alexander, S., Peterson, J. R., Snider, T. N., Levi, B., Lee, B., & Mishina, Y. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022202 · Cited by 272
Diverse Role of TGF-β in Kidney Disease
Gu, Y.-Y., Liu, X.-S., Huang, X.-R., Yu, X.-Q., & Lan, H.-Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00123 · Cited by 257
“Subsequently, the Smad2/3/4 complex translocate into the nucleus to regulate transcription of target genes, inducing α-smooth muscle actin (α-SMA), collagens, and inhibitory Smad7 (Nakao et al., 1997; Miyazawa and Miyazono, 2017).”
BackgroundA Metabolic Basis for Endothelial-to-Mesenchymal Transition
Xiong, J., Kawagishi, H., Yan, Y., Liu, J., Wells, Q. S., Edmunds, L. R., Fergusson, M. M., Yu, Z.-X., Rovira, I. I., Brittain, E. L., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.010 · Cited by 268
“…how acetyl-CoA levels might regulate EndoMT, we took advantage of previous observations that SMAD7 acts as a potent inhibitor of TGFβ signaling (Miyazawa and Miyazono, 2017) and that the post-translational acetylation of SMAD7 on two lysine residues (K64 and K70) has been demonstrated to…”
The BMP Pathway and Its Inhibitors in the Skeleton
Lowery, J. W., & Rosen, V. (2018) · Physiological Reviews · doi:10.1152/physrev.00028.2017 · Cited by 250
Yue, Y., Meng, K., Pu, Y., & Zhang, X. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.018 · Cited by 240
“This will allow the TGF-β type II receptors to phosphorylate the TGF-β type I receptor kinase domain, following the phosphorylation of the SMAD proteins[37].”
BackgroundTransforming Growth Factor-Beta (TGF-β) Signaling in Cancer-A Betrayal Within
Baba, A. B., Rah, B., Bhat, G. R., Mushtaq, I., Parveen, S., Hassan, R., Hameed Zargar, M., & Afroze, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.791272 · Cited by 224
“In addition to L3 loop, a three finger-like structure in Smad seven provides additional support to bind to TGFβRI (Miyazawa and Miyazono, 2017).”
BackgroundInfluentialThe Pathogenesis of Cardiac Fibrosis: A Review of Recent Progress
Maruyama, K., & Imanaka-Yoshida, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052617 · Cited by 205
“They can interact with TβRI and competitively inhibit SMAD2 and SMAD3 [116,120].”
BackgroundInfluentialTGF‐β signaling: A recap of SMAD‐independent and SMAD‐dependent pathways
Aashaq, S., Batool, A., Mir, S. A., Beigh, M. A., Andrabi, K. I., & Shah, Z. A. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30529 · Cited by 211
Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
Lu, Q., Yang, M.-F., Liang, Y.-J., Xu, J., Xu, H.-M., Nie, Y.-Q., Wang, L.-S., Yao, J., & Li, D.-F. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s353038 · Cited by 200
Bulle, A., & Lim, K.-H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00341-1 · Cited by 201
Hilgendorf, I., Frantz, S., & Frangogiannis, N. G. (2024) · Circulation Research · doi:10.1161/circresaha.124.323658 · Cited by 180
Pivotal Role of TGF-β/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players
Saadat, S., Noureddini, M., Mahjoubin-Tehran, M., Nazemi, S., Shojaie, L., Aschner, M., Maleki, B., Abbasi-kolli, M., Rajabi Moghadam, H., Alani, B., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.588347 · Cited by 179
Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy
Peng, M.-L., Fu, Y., Wu, C.-W., Zhang, Y., Ren, H., & Zhou, S.-S. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.907757 · Cited by 179
A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
Huynh, L., Hipolito, C., & ten Dijke, P. (2019) · Biomolecules · doi:10.3390/biom9110743 · Cited by 171
“SMAD7 controls the duration and intensity of TGF-β-induced biological responses [15,17] and its induction is a means for crosstalk of other pathways with the TGF-β signaling pathway.”
BackgroundTGF-β/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment
Li, S.-N., & Wu, J.-F. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-1552-y · Cited by 163
Bone Morphogenetic Proteins in Vascular Homeostasis and DiseasePreprint
Goumans, M., Zwijsen, A., ten Dijke, P., & Bailly, S. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a031989 · Cited by 177
“Inhibitory Smads (I-Smads, Smad6, and Smad7) inhibit BMP signaling through various mechanisms, including interfering with the interactions between R-Smads and type I receptors, downregulation of cell surface type I receptors, prevention of complex formation by R-Smads and co-Smads, and transcriptional regulation in th…”
BackgroundAstrocytes and the TGF-β1 Pathway in the Healthy and Diseased Brain: a Double-Edged Sword
Diniz, L. P., Matias, I., Siqueira, M., Stipursky, J., & Gomes, F. C. A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1396-y · Cited by 159
Inui, N., Sakai, S., & Kitagawa, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116107 · Cited by 169
“They are inhibitory Smads (I-Smad) and Smadcofactors [70].”
BackgroundTransforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity
Xue, V. W., Chung, J. Y., Córdoba, C. A. G., Cheung, A. H. K., Kang, W., Lam, E. W. ‐., Leung, K. T., To, K., Lan, H. Y., & Tang, P. M. (2020) · Cancers · doi:10.3390/cancers12113099 · Cited by 171
“Meanwhile, the TGF-β/Smad pathway also has a negative feedback mechanism mediated through Smad7 competitive binding to TGFBR1 and blocking the TGF-β/Smad pathway signalling [10].”
BackgroundTransforming Growth Factor-Beta1 in Diabetic Kidney Disease
Zhao, L., Zou, Y., & Liu, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00187 · Cited by 160
“…in mesangial cells and glomerular endothelial cells, has been implicated in activating TGF-β1 by generation of ROS from nicotinamide adenine dinucleotide phosphate oxidases (Lee, 2011; Morales et al., 2012) or by activating protein kinase C- and p38 MAPK-dependent pathways (Weigert et al., 2002).”
BackgroundThe Interactivity between TGFβ and BMP Signaling in Organogenesis, Fibrosis, and Cancer
Dituri, F., Cossu, C., Mancarella, S., & Giannelli, G. (2019) · Cells · doi:10.3390/cells8101130 · Cited by 157
Intracellular and extracellular TGF-β signaling in cancer: some recent topics
Miyazono, K., Katsuno, Y., Koinuma, D., Ehata, S., & Morikawa, M. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0646-8 · Cited by 157
Self-citationMicroRNA Control of TGF-β Signaling
Suzuki, H. I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071901 · Cited by 148
“The inhibitory Smads (I-Smads), which are namely Smad6 and Smad7, can inhibit R-Smad activation and overall signal strength [55].”
BackgroundSpecification of BMP Signaling
Nickel, J., & Mueller, T. D. (2019) · Cells · doi:10.3390/cells8121579 · Cited by 135
Jann, J., Gascon, S., Roux, S., & Faucheux, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207597 · Cited by 145
Organ Fibrosis and Autoimmunity: The Role of Inflammation in TGFβ-Dependent EMT
Sisto, M., Ribatti, D., & Lisi, S. (2021) · Biomolecules · doi:10.3390/biom11020310 · Cited by 142
The role of Smad signaling cascades in cardiac fibrosis
Hanna, A., Humeres, C., & Frangogiannis, N. G. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109826 · Cited by 132
“The I-Smads Smad6 and Smad7 are induced following TGF-β stimulation and compete with R-smads for their binding to activated TβRI or Smad4, while also mediating TβRI degradation by recruitment of Smurf ubiquitin ligases [54].”
BackgroundThe role of TGF-β superfamily signaling in neurological disorders
Kashima, R., & Hata, A. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx124 · Cited by 138
Humeres, C. D., Shinde, A. V., Hanna, A., Alex, L., Hernández, S. C., Li, R., Chen, B., Conway, S. J., & Frangogiannis, N. G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146926 · Cited by 132
“Third, Smad7 has been suggested to interfere with formation of the R-Smad–Smad4 complex, thus preventing translocation of R-Smads to the nucleus (47).”
InfluentialFeedback regulation of TGF-β signaling
Yan, X., Xiong, X., & Chen, Y.-G. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx129 · Cited by 128
The role of bone morphogenetic protein signaling in vascular calcification
Yang, P. B., Troncone, L., Augur, Z. M., Kim, S. S., McNeil, M. E., & Yu, P. B. (2020) · Bone · doi:10.1016/j.bone.2020.115542 · Cited by 127
Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
Wang, J., Lin, S., Brown, J. M., Wagoner, D. R. V., Fiocchi, C., & Rieder, F. (2021) · Immunological Reviews · doi:10.1111/imr.12974 · Cited by 127
TGF-β Family Signaling in Epithelial Differentiation and Epithelial–Mesenchymal Transition
Kahata, K., Dadras, M. S., & Moustakas, A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022194 · Cited by 132
The Role of TGF-β and Its Receptors in Gastrointestinal Cancers
Luo, J., Chen, X., & Li, P. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.11.010 · Cited by 122
Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
Wang, K., & Lǐ, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1191759 · Cited by 127
Arginine Methylation Initiates BMP-Induced Smad Signaling
Xu, J., Wang, A. H., Osés-Prieto, J. A., Makhijani, K., Katsuno, Y., Pei, M., Yan, L., Zheng, Y. G., Burlingame, A. L., Brückner, K., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.004 · Cited by 113
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111
“The high-affinity ligands bind ActRIIa/b before ALK4/5, whereas the opposite occurs with the low-affinity ligands (41, 200, 201).”
BackgroundInfluentialSmad3–STAT3 crosstalk in pathophysiological contexts
Itoh, Y., Saitoh, M., & Miyazawa, K. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx118 · Cited by 106
“Negative-feedback molecules that inhibit phosphorylation of latent transcription factors play crucial roles in fine-tuning of signaling intensity as well as duration: Smad7 for the Smad signaling pathway [40], and SOCS1/3 for the STAT3 signaling pathway [41].”
Self-citationExploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression
Ansari, Z., Chaurasia, A., Neha, Sharma, N., Bachheti, R. K., & Gupta, P. C. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.05.007 · Cited by 105
Current perspectives on inhibitory SMAD7 in health and disease
van Capelle, C. D. C., Spit, M., & ten Dijke, P. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1828260 · Cited by 102
Receptor binding competition: A paradigm for regulating TGF-β family action
Martínez-Hackert, E., Sundan, A., & Holien, T. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.09.003 · Cited by 99
Li, Y., Fan, W., Link, F., Wang, S., & Dooley, S. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100397 · Cited by 92
Transforming growth factor‐β1 in intrauterine adhesion
Abudukeyoumu, A., Li, M., & Xie, F. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13262 · Cited by 91
TGFβ family signaling and development
Jia, S., & Meng, A. (2021) · Development · doi:10.1242/dev.188490 · Cited by 96
Bone morphogenic proteins in iron homeostasis
Xiao, X., Alfaro-Magallanes, V. M., & Babitt, J. L. (2020) · Bone · doi:10.1016/j.bone.2020.115495 · Cited by 92
“Inhibitory SMADs have also been demonstrated to trigger the dephosphorylation and/or degradation of BMP receptors, block the phosphorylation of RSMADs, and mediate SMAD4 degradation in other contexts [54, 55].”
BackgroundThe context-dependent, combinatorial logic of BMP signaling
Klumpe, H. E., Langley, M. A., Linton, J. M., Su, C. J., Antebi, Y. E., & Elowitz, M. B. (2022) · Cell Systems · doi:10.1016/j.cels.2022.03.002 · Cited by 92
Bone Morphogenetic Protein–Based Therapeutic Approaches
Lowery, J. W., & Rosen, V. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022327 · Cited by 89
“Additionally, transcriptional regulation by Smads can be blocked by interaction with inhibitory proteins such as c-Ski or the c-Ski-like proto-oncogene product SnoN (SKIL) (Hill 2016; Miyazawa and Miyazono 2017).”
BackgroundKatsuno, Y., Qin, J., Osés-Prieto, J. A., Wang, H., Jackson‐Weaver, O., Zhang, T., Lamouille, S., Wu, J., Burlingame, A. L., Xu, J., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002027 · Cited by 83
“Smad6 is known to inhibit BMP-induced Smad activation, while Smad6 and Smad7 both target TGF-β-, activin- and BMP-induced Smad signaling (13).”
BackgroundSMAD4 feedback regulates the canonical TGF-β signaling pathway to control granulosa cell apoptosis
Du, X., Pan, Z., Li, Q., Liu, H., & Li, Q. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0205-2 · Cited by 79
BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration
Herrera, B. M., Addante, A., & Sánchez, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms19010039 · Cited by 79
“The R-Smads include Smad1, Smad2, Smad3, Smad5 and Smad8/9; the co-Smad includes only Smad4, which interacts with R-Smads to participate in signalling; and finally, the I-Smad include Smad6 and Smad7, which negatively regulate Smads activation and regulate receptor stability [17,18].”
BackgroundContextual Regulation of TGF-β Signaling in Liver Cancer
Tu, S., Huang, W., Huang, C., Luo, Z., & Yan, X. (2019) · Cells · doi:10.3390/cells8101235 · Cited by 81
Bu, M. T., Chandrasekhar, P., Ding, L., & Hugo, W. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108211 · Cited by 82
“This negative feedback loop prevents continuous activation of the TGF-β signaling pathway (Miyazawa & Miyazono, 2017).”
BackgroundSignaling regulation during gastrulation: Insights from mouse embryos and in vitro systems
Morgani, S. M., & Hadjantonakis, A. (2019) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2019.11.011 · Cited by 79
Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance
Zabkiewicz, C., Resaul, J., Hargest, R., Jiang, W. G., & Ye, L. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0139 · Cited by 78
“A full colour version of the figure is available at http://dx.doi.org/10.1530/ ERC-17-0139 24: 10 prevent complex formation between R-Smads and Smad-4, thus affecting transcriptional regulation in the nucleus, which was well reviewed previously (Miyazono 2008, Bragdon et al .”
InfluentialBone Morphogenetic Protein Signaling in Cancer; Some Topics in the Recent 10 Years
Ehata, S., & Miyazono, K. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.883523 · Cited by 72
Self-citationContext-dependent TGFβ family signalling in cell fate regulation
Richardson, L., Wilcockson, S. G., Guglielmi, L., & Hill, C. S. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00638-3 · Cited by 70
SETDB1 regulates SMAD7 expression for breast cancer metastasis
Ryu, T. Y., Kim, K., Kim, S., Oh, J., Min, J., Jung, C., Son, M., Kim, D., & Cho, H. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.2.235 · Cited by 68
Old wine in new bottles: Kaempferol is a promising agent for treating the trilogy of liver diseases
Xiao, X., Hu, Q., Deng, X., Shi, K., Zhang, W., Jiang, Y., Ma, X., Zeng, J., & Wang, X. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.106005 · Cited by 70
Wang, Y., Pan, Z., Du, X., Zhang, J., & Li, Q. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26431 · Cited by 64
“TGFBR1, the type I receptor of the canonical TGF-β signaling pathway, is the main functional target of SMAD7, and SMAD7 attenuates TGFBR1 stability and function through various molecular mechanisms (Kowanetz et al., 2008; Li, 2015; Miyazawa & Miyazono, 2017).”
BackgroundExploring TGF-β Signaling in Cancer Progression: Prospects and Therapeutic Strategies
Sheikh, K., Amjad, M., Irfan, M., Anjum, S., Majeed, T., Riaz, M. U., Jassim, A. Y., Sharif, E., & Ibrahim, W. N. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s493643 · Cited by 68
“…cell motility, adhesion and growth takes place via Rhodopsin (Rho) like GTPase pathway, 119 cell migration and tight junctions via PAR6 regulators, 120 cell proliferation, survival and metastasis via Extracellular Signal-Regulated Kinases (ERK)/Mitogen Activated Protein Kinases (MAPK) and…”
Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes
Verma, A. K., Suragani, R. N. V. S., Aluri, S., Shah, N. N., Bhagat, T. D., Alexander, M. J., Komrokji, R. S., & Kumar, R. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133678 · Cited by 64
Wang, X., Zhao, Y., Sun, L., Shi, Y., Li, Z., Zhao, X., Xu, C., Ji, H., Wang, M., Xu, W., et al. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3496 · Cited by 63
“It can inhibit TGF-β I-induced phosphorylation of Smad2/3 and interfere with the interaction between other Smad proteins or receptors to inhibit downstream gene transcription (13).”
To Ub or not to Ub: a regulatory question in TGF-β signaling
Liu, J., Jin, J., Liang, T., & Feng, X. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.06.001 · Cited by 62
TXNIP Suppresses the Osteochondrogenic Switch of Vascular Smooth Muscle Cells in Atherosclerosis
Woo, S., Kyung, D. S., Lee, S. H., Park, K. S., Kim, M., Kim, K., Kwon, H., Won, Y., Choi, I., Park, Y., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.321538 · Cited by 64
TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity
Ali, S., Rehman, M. U., Yatoo, A. M., Arafah, A. M., Khan, A., Rashid, S., Majid, S., Ali, A., & Ali, M. N. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175678 · Cited by 64
Osteoblast role in the pathogenesis of rheumatoid arthritis
Berardi, S., Corrado, A., Maruotti, N., Cici, D., & Cantatore, F. P. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06288-y · Cited by 62
“SMAD6 and SMAD7 inhibit receptor complex activation [49].”
BackgroundStructural basis for ALK2/BMPR2 receptor complex signaling through kinase domain oligomerization
Agnew, C., Ayaz, P., Kashima, R., Loving, H. S., Ghatpande, P., Kung, J. E., Underbakke, E. S., Shan, Y., Shaw, D. E., Hata, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25248-5 · Cited by 65
The Role of TGF-β during Pregnancy and Pregnancy Complications
Wen, B., Liao, H., Lin, W., Li, Z., Ma, X.-Q., Xu, Q., & Yu, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316882 · Cited by 62
“Ligands, including TGF-β , Activins, inhibins, Nodal, and bone morphogenetic proteins (BMP), interact with transmembrane receptor type I and type II complexes on the cell surface [2,3].”
BackgroundZhang, Y., Lu, Y., Machuki, J. O., Ge, L., Qian, Y., Chen, L., Hu, X., Li, F., Wei, H., Zhang, C., et al. (2018) · BioMed Research International · doi:10.1155/2018/8730593 · Cited by 60
The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease
Peng, Q., Shan, D., Cui, K., Li, K. S., Zhu, B., Wu, H., Wang, B., Wong, S., Norton, V., Dong, Y., et al. (2022) · Cells · doi:10.3390/cells11111834 · Cited by 59
“TGFβ family ligands activate particular R-Smads via distinct receptor complexes [64,68], which can translocate into the nucleus and modulate certain transcriptional genes’ responses [69].”
BackgroundSMAD6 variants in craniosynostosis: genotype and phenotype evaluation
Calpena, E., Cuellar, A., Bala, K., Swagemakers, S. M. A., Koelling, N., McGowan, S. J., Phipps, J. M., Balasubramanian, M., Cunningham, M. L., Douzgou, S., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0817-2 · Cited by 62
The versatility and paradox of BMP signaling in endothelial cell behaviors and blood vessel function
Kulikauskas, M. R., Shaka, X., & Bautch, V. L. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04033-z · Cited by 60
TGF-β signaling regulates differentiation of MSCs in bone metabolism: disputes among viewpoints
Wei, E., Hu, M., Wu, L., Pan, X., Zhu, Q., Liu, H., & Liu, Y. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03761-w · Cited by 58
Huang, M., Kim, H.-G., Zhong, X., Dong, C., Zhang, B., Fang, Z., Zhang, Y., Lu, X., Saxena, R., Liu, Y., et al. (2019) · Hepatology · doi:10.1002/hep.30820 · Cited by 64
Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment
Stuelten, C. H., & Zhang, Y. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764727 · Cited by 61
Kaminska, B., & Cyranowski, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-30651-9_9 · Cited by 57
Gungor, M. Z., Uysal, M., & Şentürk, Ş. (2022) · Cancers · doi:10.3390/cancers14040940 · Cited by 58
“Much like the R-Smads and Smad4, the I-Smads have a conserved MH2 domain that facilitates the interaction with R-Smads and TGFβRI, thus preventing R-Smad recruitment and phosphorylation [42,43] (Figure 1).”
BackgroundUnderstanding Drivers of Ocular Fibrosis: Current and Future Therapeutic Perspectives
Mallone, F., Costi, R., Marenco, M., Plateroti, R., Minni, A., Attanasio, G., Artico, M., & Lambìase, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111748 · Cited by 55
“Specifically viral and non-viral gene transfer techniques based on TGFβ/Smads2/3/7 have been studied in vitro and in vivo animal models.”
BackgroundInfluentialProteasome-dependent degradation of Smad7 is critical for lung cancer metastasis
Lu, T., Shen, S., Huang, Q., Fu, J., Wang, T., Pan, L., Zhang, P., Chen, G., Huang, T., Li, K., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0459-6 · Cited by 52
TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson’s Disease
Muñoz, M.-D., de la Fuente, N., & Sánchez‐Capelo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020590 · Cited by 54
Tang, J., Liu, F., Cooper, M. E., & Chai, Z. (2022) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2022.2133698 · Cited by 51
Therapeutic targeting of TGF ‐β in lung cancer
Aftabi, S., Behrooz, A. B., Cordani, M., Rahiman, N., Sadeghdoust, M., Aligolighasemabadi, F., Pistorius, S., Alavizadeh, S. H., Taefehshokr, N., & Ghavami, S. (2024) · FEBS Journal · doi:10.1111/febs.17234 · Cited by 52
“These proteins directly control the activity of TGF-b receptors by ubiquitinating and degrading the TGF b RI receptor, which generally facilitates the growth and spread of lung cancer [195 – 197].”
Divolis, G., Stavropoulos, A., Manioudaki, M., Apostolidou, A. C., Doulou, A., Gavriil, A., Dafnis, I., Chroni, A., Mummery, C. L., Xilouri, M., et al. (2019) · Brain Communications · doi:10.1093/braincomms/fcz028 · Cited by 54
“Activation of canonical pathways upregulates Smads 6 and 7, which function as negative feedback regulators (Miyazawa and Miyazono, 2017).”
BackgroundFibroblast Smad7 Induction Protects the Remodeling Pressure-Overloaded Heart
Humeres, C. D., Shinde, A. V., Tuleta, I., Hernández, S. C., Hanna, A., Huang, S., Venugopal, H., Aguilan, J. T., Conway, S. J., Sidoli, S., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323360 · Cited by 51
“14,15 Although early studies have attempted to study the role of Smad7 in models of hypertensive cardiomyopathy, 16,17 their findings are limited by the absence of cell-specific approaches and by the use of a hypomorphic global Smad7 mutant line (Smad7 Δ ex 1) that exhibits preserved Smad7…”
Metadata
- Authors
- Miyazawa, K., & Miyazono, K.
- Affiliations
- University of Yamanashi (JP)
- The University of Tokyo (JP)
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-12-05
- Volume
- 9
- Issue
- 3
- Pages
- a022095
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC5334261
- OpenAlex
- W2560615789
- Cited by
- 439
- References
- 211
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 43 · 2023: 56 · 2022: 61 · 2021: 78 · 2020: 56 · 2019: 33 · 2018: 32 · 2017: 19 · 2016: 2
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (15H05774)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Keywords
- inhibitory Smads, Smad6, Smad7, TGF-beta signaling, BMP signaling, Smad activation, receptor stability, non-Smad signaling, post-translational modification, phosphorylation, ubiquitination, acetylation, methylation
- MeSH terms
- Animals, Humans, Protein Conformation, Protein Processing, Post-Translational, Signal Transduction, Transforming Growth Factor beta, Smad Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.